Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||
Cash from operating activities | -12.67%549.53M | -75.10%629.29M | 48.56%2.53B | 137.64%1.7B | -19.51%716.02M | 889.56M |
Net profit before non-cash adjustment | -48.30%357.61M | -70.47%691.68M | 81.94%2.34B | 101.68%1.29B | -35.68%638.32M | --992.46M |
Total adjustment of non-cash items | -50.79%145.3M | 125.01%295.24M | -3.82%131.21M | -26.95%136.41M | 198.22%186.73M | ---190.12M |
-Depreciation and amortization | 22.26%128.75M | -14.08%105.3M | -6.87%122.56M | -5.50%131.59M | 3.91%139.25M | --134.01M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | ---19.68M |
-Disposal profit | -83.03%32.87M | 2,593.07%193.66M | --7.19M | ---- | ---- | ---334.49M |
-Other non-cash items | -337.95%-16.32M | -355.21%-3.73M | -69.71%1.46M | -89.85%4.82M | 58.09%47.48M | --30.03M |
Changes in working capital | 113.04%46.63M | -757.93%-357.63M | -80.43%54.36M | 354.80%277.8M | -225.01%-109.03M | --87.22M |
-Change in receivables | 44.77%-61.79M | -266.52%-111.88M | 41.84%-30.52M | -172.36%-52.48M | -44.47%72.53M | --130.62M |
-Change in inventory | 167.17%9.77M | -189.79%-14.55M | 287.87%16.21M | 38.16%4.18M | -83.20%3.02M | --18M |
-Change in payables | 84.85%-23.91M | -243.42%-157.85M | 78.74%110.06M | 242.50%61.58M | -164.45%-43.21M | --67.05M |
-Change in accrued expense | 2,756.87%34.51M | 105.89%1.21M | -23.43%-20.52M | 70.67%-16.62M | -113.02%-56.67M | ---26.6M |
-Provision for loans, leases and other losses | -64.27%-30.96M | -174.08%-18.85M | 235.04%25.44M | 79.82%-18.84M | -353.63%-93.39M | --36.82M |
-Changes in other current assets | 313.58%119M | -20.31%-55.72M | -115.44%-46.31M | 3,350.13%299.99M | 106.27%8.7M | ---138.66M |
Dividends paid (cash flow from operating activities) | ||||||
Dividends received (cash flow from operating activities) | ||||||
Interest paid (cash flow from operating activities) | 18.85%-2.62M | 24.59%-3.23M | 21.27%-4.28M | 55.46%-5.43M | 59.97%-12.2M | -30.47M |
Interest received (cash flow from operating activities) | 296.48%18.9M | 76.40%4.77M | 39.33%2.7M | 41.92%1.94M | 23.60%1.37M | 1.11M |
Tax refund paid | 110.01%117.15M | -162.66%-1.17B | -137.45%-445.43M | -7,262.01%-187.58M | 19.37%-2.55M | -3.16M |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0.00%-1K | -200.00%-1K | 1K |
Operating cash flow | 226.68%682.97M | -125.91%-539.12M | 37.75%2.08B | 114.97%1.51B | -18.02%702.64M | --857.04M |
Investing cash flow | ||||||
Net PPE purchase and sale | -154.81%-29.25M | -9.36%-11.48M | 81.56%-10.5M | 67.98%-56.91M | -1,155.12%-177.74M | ---14.16M |
Net intangibles purchase and sale | ---8.1M | --0 | 13.64%-9.13M | -136.37%-10.57M | 88.10%-4.47M | ---37.59M |
Net business purchase and sale | --0 | -2,177.86%-140.28M | --6.75M | ---- | -108.80%-32.84M | --373.14M |
Net investment product transactions | 97.06%-28.24M | ---960M | --0 | ---- | ---- | ---- |
Advance cash and loans provided to other parties | ---500M | --0 | ---- | ---- | ---- | ---35M |
Repayment of advance payments to other parties and cash income from loans | 1,280.30%227.89M | 2,401.52%16.51M | 0.00%660K | -24.14%660K | -69.69%870K | --2.87M |
Net changes in other investments | -4,169.69%-184.66M | -3,280.15%-4.33M | -99.17%136K | 106.98%16.46M | -206.52%-235.95M | --221.51M |
Investing cash flow | 52.49%-522.37M | -9,002.39%-1.1B | 76.01%-12.08M | 88.81%-50.36M | -188.13%-450.13M | --510.76M |
Financing cash flow | ||||||
Net issuance payments of debt | 40.24%-148.49M | -412.47%-248.49M | 74.45%-48.49M | -141.06%-189.77M | 97.09%-78.72M | ---2.71B |
Net common stock issuance | -1,016.89%-94.16M | 87.66%10.27M | -99.26%5.47M | --739.86M | ---- | ---- |
Increase or decrease of lease financing | 39.65%-9.74M | 36.64%-16.14M | 19.25%-25.48M | 31.86%-31.55M | -8.09%-46.3M | ---42.83M |
Cash dividends paid | -3.19%-244.58M | -100.57%-237.01M | -427.07%-118.17M | 0.00%-22.42M | ---22.42M | ---- |
Net other fund-raising expenses | 0.00%-1K | ---1K | ---- | ---- | ---- | ---- |
Financing cash flow | -1.14%-496.96M | -163.24%-491.37M | -137.62%-186.66M | 436.50%496.13M | 94.64%-147.44M | ---2.75B |
Net cash flow | ||||||
Beginning cash position | -35.08%3.94B | 44.92%6.07B | 87.59%4.19B | 4.94%2.23B | -37.92%2.13B | --3.43B |
Current changes in cash | 84.21%-336.36M | -213.18%-2.13B | -3.79%1.88B | 1,761.81%1.96B | 107.60%105.07M | ---1.38B |
Cash adjustments other than cash changes | 0.00%-1K | -200.00%-1K | --1K | ---- | -100.00%-1K | --82.23M |
End cash Position | -8.53%3.61B | -35.08%3.94B | 44.92%6.07B | 87.59%4.19B | 4.94%2.23B | --2.13B |
Free cash flow | 217.26%645.62M | -126.71%-550.59M | 42.84%2.06B | 177.26%1.44B | -35.37%520.43M | --805.28M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |